Outpatient Vascular Care: Good, bad or ugly?
BY ANISH KOKA
Filling in the holes of recent stories in the New York Times, and Propublica on the outpatient care of patients with peripheral arterial disease
Most have gotten used to egregiously bad coverage of current events that fills the pages of today’s New York Times, but even by their now very low standards a recent telling of a story about peripheral artery disease was very bad.
The scintillating allegation by Katie Thomas, Jessica Silver-Greenberg and Robert Gebeloff is that “medical device makers are bankrolling doctors to perform artery clearing procedures that can lead to amputations...
Source: The Health Care Blog - July 24, 2023 Category: Consumer Health News Authors: Ryan Bose-Roy Tags: Medical Practice Anish Koka Medical Devices Outpatient vascular care Source Type: blogs
What are the Actions and Inactions of Liberia ’s Banking Sector in the Employment and Accessibility of Persons with Disabilities in their Business Strategies
Sahr Nouwah (Independent), What are the Actions and Inactions of Liberia ’s Banking Sector in the Employment and Accessibility of Persons with Disabilities in their Business Strategies (2023): The main goal of this research is to investigate actions and inactions within... (Source: HealthLawProf Blog)
Source: HealthLawProf Blog - February 18, 2023 Category: Medical Law Authors: Katharine Van Tassel Source Type: blogs
Congress Should Require TPS for Immigrants from Nations With Armed Conflicts
David J. BierSince 1990, the executive branch has had the authority from Congress to provide Temporary Protected Status (TPS) to people already in the United States who are from countries in which an “ongoing armed conflict within the state" exists. A bipartisan group in Congress wrote a letter to the Biden administration requesting that it designate Ukraine for TPS, and then they also proposed legislation torequire it to use its authority.Finally, the administrationhas relented (with the full details still to be filled in). But Congress should still recognize the procedural problem with giving total discretion to th...
Source: Cato-at-liberty - March 4, 2022 Category: American Health Authors: David J. Bier Source Type: blogs
Another factor contributing to PTSD onset; the NUMBER of traumatic events
A scientific friend and colleague, Professor Thomas Elbert from Konstanz University in Germany, has had a long interest in applying “simple” treatments to individuals suffering from post-traumatic stress disorders (PTSDs). With his wife Maggie and others, he has developed and applied such treatments to war victims, primarily in Africa and Sri Lanka. There, literally millions of individuals have endured great personal losses and multiple horrifying experiences. If and when these individuals are resettled back to their homes in Uganda or Liberia or Sierra Leone or Rwanda or Sudan or the Congo Republic or wherever...
Source: On the Brain by Dr. Michael Merzenich, Ph.D. - May 1, 2019 Category: Neuroscience Authors: Dr. Merzenich Tags: Brain Fitness Brain Trauma, Injury Schizophrenia, Bipolar Disorder, et alia Source Type: blogs
Senate GOP Bill Doesn ’t Extend TPS. It Guts It
President Trumpannounced on Saturday that he had a new plan to open government that includes “a three-year extension of temporary protected status or TPS.” But as in the case of DACA—for reasons I explainedhere—theactual legislation that Senate Majority Leader Mitch McConnell introduced to implement his proposal does not extend TPS. Rather, it ends it as it exists now, and replaces with an entirely different program with much more restrictive criteria.Temporary protective status, or TPS, is granted to nationals of country where the government feels it could not, at one time or another, send people back to due to a ...
Source: Cato-at-liberty - January 22, 2019 Category: American Health Authors: David Bier Source Type: blogs
TWiV 505: Rosebola
The TWiV hosts review persistence of Ebola virus after the end of the Liberian outbreak, and the potential role of two herpesviruses in the pathogenesis of Alzheimer’s disease. <span data-mce-type=”bookmark” style=”display: inline-block; width: 0px; overflow: hidden; line-height: 0;” class=”mce_SELRES_start”></span><span data-mce-type=”bookmark” style=”display: inline-block; width: 0px; overflow: hidden; line-height: 0;” class=”mce_SELRES_start”></span>&lt;span data-mce-type=̶...
Source: virology blog - August 5, 2018 Category: Virology Authors: Vincent Racaniello Tags: This Week in Virology alzheimer's disease ebola virus exanthem subitum herpesvirus hhv-6 HHV-7 human herpesvirus persistence recrudescence roseola transmission viral viruses Source Type: blogs
Ebola Vaccine – Have We Considered Sustainability?
Ebola is a devastating disease, and not a way anyone would want to die. As a nurse who worked in a 120-bed Ebola treatment unit in Liberia in 2014, I have seen the horror of this completely ravaging disease on individuals, families, and whole communities. To contract the disease is terrifying and certainly made worse
The post Ebola Vaccine – Have We Considered Sustainability? appeared first on Johns Hopkins Nursing Magazine. (Source: Nursing Blogs at Johns Hopkins University)
Source: Nursing Blogs at Johns Hopkins University - June 20, 2018 Category: Nursing Authors: Online Editor Tags: On the Pulse Community health DRC Ebola Ebola response Global health vaccination Vaccine Source Type: blogs
In Africa, Presidential Term Limits Are Working
World news regularly features headlines about African power grabs and constitutional coups. Presidents Ernest Bai Koroma of Sierra Leone and Ellen Johnson Sirleaf of Liberia both adhered to term limits, stepping aside after finishing their second terms. Are they part of a broader trend? (Source: The RAND Blog)
Source: The RAND Blog - April 24, 2018 Category: Health Management Authors: Alexander H. Noyes Source Type: blogs
The future of primary care is as bright as we choose to make it
I decided to become a doctor at the tender age of eight when I met my first patient — my grandmother, Grandma Sylvia. After spending two years in the midst of the Liberian civil war, she arrived in the United States with diabetes, hypertension, obesity and nearly blind due to glaucoma. One of my new chores was helping administer her daily insulin injection.
I also had the privilege of accompanying Grandma Sylvia to her doctor’s appointments during which she saw a different doctor every visit. Each office visit she had to retell portions of her medical history to the often hurried young physicians (who I know now were p...
Source: Kevin, M.D. - Medical Weblog - April 3, 2018 Category: General Medicine Authors: < a href="https://www.kevinmd.com/blog/post-author/sylvia-gonsahn-bollie" rel="tag" > Sylvia Gonsahn-Bollie, MD < /a > Tags: Physician Primary Care Source Type: blogs
The Luxury to Choose
By TRAVIS BIAS, MD
The 80 year-old woman lay on her mat, her legs powerless, looking up at the small group that had come to visit her. There were no more treatment options left. The oral liquid morphine we had brought in the small plastic bottle had blunted her pain. But, she would be dead in the coming days. The cervical cancer that was slowly taking her life is a notoriously horrible disease if left undetected and untreated and that is exactly what had happened in this case.
We had traveled hours by van along dirt roads to this village with a team of health workers from Hospice Africa Uganda, the country’s authority o...
Source: The Health Care Blog - February 25, 2018 Category: Consumer Health News Authors: John Irvine Tags: Uncategorized Gardasil Hospice Africa Uganda vaccines Source Type: blogs
Treat the Pathway, not the Gene (from Precision Medicine and the Reinvention of Human Disease)
Treat the key pathway, not the genetic mutation (fromPrecision Medicine and the Reinvention of Human Disease)Some of the earliest and most successful Precision Medication drugs have targeted specific mutations occurring in specific subsets of diseases. One such example is ivacaftor, which targets the G551D mutation present in about 4% of individuals with cystic fibrosis [135]. It is seldom wise to argue with success, but it must be mentioned that the cost of developing a new drug is about $5 billion [136]. To provide some perspective, $5 billion exceeds the total gross national product of many countries, including Sierra L...
Source: Specified Life - February 5, 2018 Category: Information Technology Tags: clinical trials convergent pathways cost of precision medicine precision treatment Source Type: blogs
What ’s New and In the Queue for Academic Medicine
What’s New: A Preview of the December Issue
The December issue of Academic Medicine is now available! Read the entire issue online at academicmedicine.org or on your iPad using the Academic Medicine for iPad app. Highlights from the issue include:
Beyond “Dr. Feel-Good”: A Role for the Humanities in Medical Education
Kumagai proposes several unique ways in which the arts and humanities contribute to the development of physicians who practice with excellence, compassion, and justice.
Exploring Integration in Action: Competencies as Building Blocks of Expertise
Mylopoulos and colleagues find that understanding integ...
Source: Academic Medicine Blog - December 6, 2017 Category: Universities & Medical Training Authors: Journal Staff Tags: Featured Issue Preview empathy global health health disparities medical education medical students Source Type: blogs
A beacon of light in these tumultuous times
In these tumultuous political and cultural times, it’s easy to presume the future is bleak. However, after attending a conference centered around medicine, public health, and medical science innovation, replete with remarkable stories of human perseverance, resilience, and courage, I felt humbled, inspired, and hopeful. In that order.
Who cannot be awed listening to the one physician who kept treating desperately ill patients when the entire rest of the medical staff abandoned a Liberian hospital at the outbreak of the Ebola epidemic? Or the lone Syrian female OB/GYN who continued to serve her patients, often performing ...
Source: Kevin, M.D. - Medical Weblog - December 6, 2017 Category: General Medicine Authors: < a href="https://www.kevinmd.com/blog/post-author/robert-baker" rel="tag" > Robert Baker, MD < /a > Tags: Physician Public Health & Policy Source Type: blogs
Prior Presidents ’ “Travel Bans” Are Different From President Trump’s Ban
President Trump ’stravel ban Proclamation that bans immigration and travel from seven countries (and limits it from an eighth) is based on authority in immigration law that other presidents have used. But all but one of these bans were quite different from President Trump ’s. They banned at most a few thousand—almost always specifically named—individuals based on their personal conduct, not their nationality. In the one exception, not all nationals were banned, and the requirements to end the ban were very clear. Neither of which can be said for the Trump ban.Different in ScaleNo president has attempted to ban as m...
Source: Cato-at-liberty - November 16, 2017 Category: American Health Authors: David Bier Source Type: blogs
